News
Life Sciences M&A Values Soar in 2011 May 14, 2012 | Press Release
Life Sciences M&A Activity Heats Up in April, says Burrill & Company May 01, 2012 | Press Release
Burrill & Company Leads $12.9 Million Series E Round In WhiteGlove Health April 16, 2012 | Press Release
See all News
Linda Molnar
Managing DirectorDr. Molnar has advised early-stage life sciences companies in the structuring and management of corporate development and financing opportunities in order to maximize capital efficiency by utilizing non-dilutive funding. Previously she served as a consultant at the National Cancer Institute, where she was instrumental in the launch and implementation of the Program in Cancer Nanotechnology. Linda has a breadth of experience in collaborations and partnerships between academic institutions, large companies, and biotechnology startups for the successful translation of fundamental research into products and businesses. She received her Ph.D. in Materials Science and Engineering from the Massachusetts Institute of Technology and her B.S. in Chemistry with Honors from the University of Pittsburgh. She also completed the Wharton Management Program.


